Lupin has unveiled an ambitious tactical plan aimed at accelerating its growth through a strong product pipeline, widened market reach, and improved financial health. The company's latest update emphasizes a tightly managed approach
The Indian Pharmacopoeia Commission (IPC) intends to work on monographs and quality standards of three important TB drugs, such as delamanid, pretomanid and a fixed-dose combination (FDC) of rifapentine and isoniazid...
Positive results from the pivotal LIBERTY-AFRS-AIMS Phase 3 trial reveal that Dupixent considerably enhanced symptoms in adults and children aged six years and older with allergic fungal rhinosinusitis (AFRS). The investigational treatment met...
Biocon Ltd. informed that its Active Pharmaceutical Ingredient (API) manufacturing facility in Visakhapatnam, Andhra Pradesh
Torrent Pharmaceuticals got the green light from the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) to produce and sell Prucalopride Oral Solution (0.2 mg/mL).
.png "Mounjaro Becomes India's Top-Selling Drug at INR100 Crore")
Eli Lilly’s anti-obesity drug Mounjaro has become India’s highest-selling pharmaceutical by value in October, with sales touching ?100 crore ($11.38 million). The surge reflects the growing demand for anti-obesity medications in a country...
Zydus Lifesciences receives tentative USFDA approval for Olaparib Tablets (100mg, 150mg) used in treating BRCA-related ovarian, breast, pancreatic, and prostate cancers.
Alembic Pharmaceuticals Limited (Alembic), a pharmaceutical company engaged in vertically integrated research and development, has announced that it has obtained final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug
Bayer’s Kerendia™ (finerenone) approved in India for HFpEF/HFmrEF, offering dual heart-kidney protection and improving outcomes in high-risk cardiovascular patients.
Zydus Lifesciences Ltd. is set to broaden its US specialty sector with non-core molecules composition Saroglitazar. The company has a plan to use the funds from its recently approved ?5,000-crore Qualified Institutional Placement
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")